These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17447590)

  • 1. [Palliation in patients with metastatic breast cancer often better with antitumour treatment than with only symptomatic treatment].
    Soetekouw PM; van Dongen R; Maas R; Bult P; Boetes C; Tjan-Heijnen VC
    Ned Tijdschr Geneeskd; 2007 Mar; 151(12):673-8. PubMed ID: 17447590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The systemic treatment of bone metastases.
    Houston SJ; Rubens RD
    Clin Orthop Relat Res; 1995 Mar; (312):95-104. PubMed ID: 7543393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiation therapy of symptomatic recurrent bladder cancer.
    Yi SK; Yoder M; Zaner K; Hirsch AE
    Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
    Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
    Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
    Manders K; van de Poll-Franse LV; Creemers GJ; Vreugdenhil G; van der Sangen MJ; Nieuwenhuijzen GA; Roumen RM; Voogd AC
    BMC Cancer; 2006 Jul; 6():179. PubMed ID: 16824210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of bone metastases in breast cancer].
    Köhler AH; Dobberstein N; Stoltmann R; Heschel U
    Zentralbl Chir; 1984; 109(7):483-9. PubMed ID: 6203258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.
    Broom R; Du H; Clemons M; Eton D; Dranitsaris G; Simmons C; Ooi W; Cella D
    J Pain Symptom Manage; 2009 Aug; 38(2):244-57. PubMed ID: 19364633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibial involvement in breast cancer: issues in diagnosis and management.
    Goyal S; Puri T; Gupta R; Suri V; Julka PK; Rath GK
    Foot (Edinb); 2010 Mar; 20(1):35-8. PubMed ID: 20434678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive treatment of bone metastases of breast cancer: a clinical analysis of 70 cases].
    Zhou J; Zhang Q; Lu H
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):284-6. PubMed ID: 11038760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates, pain and quality of life in metastatic breast cancer patients: a literature review].
    Roemer-Becuwe C; Krakowski I; Conroy T
    Bull Cancer; 2003 Dec; 90(12):1097-105. PubMed ID: 14715429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of bone metastases induces long-lasting palliation in patients with untreatable cancer.
    Belfiore G; Tedeschi E; Ronza FM; Belfiore MP; Della Volpe T; Zeppetella G; Rotondo A
    Singapore Med J; 2008 Jul; 49(7):565-70. PubMed ID: 18695866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
    Gligorov J; Lotz JP
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated limb perfusion with melphalan for femoral metastases of breast cancer: case report.
    Noorda EM; Vrouenraets BC; Nieweg OE; Pinedo HM; Kroon BB
    J Surg Oncol; 2002 Dec; 81(4):209-12. PubMed ID: 12451626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study.
    Liberman B; Gianfelice D; Inbar Y; Beck A; Rabin T; Shabshin N; Chander G; Hengst S; Pfeffer R; Chechick A; Hanannel A; Dogadkin O; Catane R
    Ann Surg Oncol; 2009 Jan; 16(1):140-6. PubMed ID: 19002530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone metastases].
    Jensen AB; Kamby C; Hansen B; Keller J
    Ugeskr Laeger; 2007 Oct; 169(44):3753-6. PubMed ID: 18028842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
    Pandit-Taskar N; Batraki M; Divgi CR
    J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
    Silberstein EB
    Semin Nucl Med; 2005 Apr; 35(2):152-8. PubMed ID: 15765378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.